Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Blood Advances
|
August 9, 2020
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
Andrés J M Ferreri, Teresa Calimeri, Maurilio Ponzoni, et al.
Blood
|
February 28, 2014
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML
Sophia Adamia, Michal Bar-Natan, Benjamin Haibe-Kains, et al.
Hematological Oncology
|
May 2, 2020
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
Andrés J M Ferreri, Marianna Sassone, Piera Angelillo, et al.
Nature Medicine
|
May 26, 2015
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine
|
January 25, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine
|
July 5, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
British Journal of Haematology
|
August 9, 2022
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
Sara Steffanoni, Teresa Calimeri, Alice Laurenge, et al.
Haematologica
|
October 27, 2022
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
Jahanzaib Khwaja, Amy A Kirkwood, Lisa K Isbell, et al.
Hemasphere
|
January 25, 2020
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, et al.
British Journal of Haematology
|
February 23, 2021
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
Andrés J M Ferreri, Teresa Calimeri, Paolo Lopedote, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Blood Advances
|
August 9, 2020
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
Andrés J M Ferreri, Teresa Calimeri, Maurilio Ponzoni, et al.
Blood
|
February 28, 2014
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML
Sophia Adamia, Michal Bar-Natan, Benjamin Haibe-Kains, et al.
Hematological Oncology
|
May 2, 2020
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
Andrés J M Ferreri, Marianna Sassone, Piera Angelillo, et al.
Nature Medicine
|
May 26, 2015
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine
|
January 25, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
Nature Medicine
|
July 5, 2024
Author Correction: The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells
Di Zhu, Zhongqiu Wang, Jian-Jun Zhao, et al.
British Journal of Haematology
|
August 9, 2022
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group
Sara Steffanoni, Teresa Calimeri, Alice Laurenge, et al.
Haematologica
|
October 27, 2022
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
Jahanzaib Khwaja, Amy A Kirkwood, Lisa K Isbell, et al.
Hemasphere
|
January 25, 2020
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, et al.
British Journal of Haematology
|
February 23, 2021
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
Andrés J M Ferreri, Teresa Calimeri, Paolo Lopedote, et al.
Page
of 6